Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 22,766 | 41,673 | 49,859 | 38,012 | 30,855 |
| Gross Profit | 22,766 | 41,673 | 49,859 | 38,012 | 30,855 |
| Operating Expenses | 56,160 | 52,410 | 70,985 | 68,424 | 49,127 |
| Operating Income | -33,394 | -10,737 | -21,126 | -30,412 | -18,272 |
| Interest Expense | -3,213 | -3,818 | -4,148 | -4,016 | -9,686 |
| Other Income | 171 | -201 | -388 | -53 | -2,859 |
| Pre-tax Income | -30,010 | -7,120 | -17,366 | -26,449 | -11,445 |
| Income Tax | -5 | -217 | -150 | 368 | 262 |
| Net Income Continuous | -30,005 | -6,903 | -17,216 | -26,817 | -11,707 |
| Net Income | $-30,005 | $-6,903 | $-17,216 | $-26,817 | $-11,707 |
| EPS Basic Total Ops | -1.10 | -0.26 | -0.64 | -1.00 | -0.44 |
| EPS Basic Continuous Ops | -1.11 | -0.26 | -0.64 | -1.00 | -0.44 |
| EPS Diluted Total Ops | -1.10 | -0.26 | -0.64 | -1.00 | -0.40 |
| EPS Diluted Continuous Ops | -1.11 | -0.26 | -0.64 | -1.00 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -1.11 | -0.26 | -0.64 | N/A | N/A |
| EBITDA(a) | $-32,575 | $-9,825 | $-20,217 | $-29,508 | $-17,457 |